February 13, 2026

Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing

Bead-free microbubble approach aims to simplify cell selection and activation for scalable cell therapy manufacturing

The Medicine Maker

February 12, 2026

FDA Approves HRT Label Changes

The agency cited updated evidence in revising hormone therapy safety language.

Conexiant

February 12, 2026

Abortion and Breast Cancer: Any Link?

Analysis of more than 30,000 breast cancer cases finds no increased risk of breast cancer following induced abortion or miscarriage

Conexiant

February 12, 2026

Training the Medicine Makers the UK Can’t Afford to Lose

Why immersive training could be critical to closing the UK’s medicines manufacturing skills gap

The Medicine Maker

February 12, 2026

New Collaboration to Automate Cell Therapy Manufacturing with Robotics

Focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology

The Medicine Maker

February 10, 2026

Why Scientists Are Revisiting a Polarizer

The nation’s top cancer institute takes a closer look at a disputed drug.

KFF Health News

February 10, 2026

Tracing Metabolic Inflexibility in Fanconi Anemia 

Stable-isotope glucose tracing reveals impaired fuel switching and altered energy use in a rare DNA-repair disorder 

The Analytical Scientist

February 10, 2026

Electronic Lab Notebooks Are Failing Scientists and Inflating R&D Costs

New survey finds outdated lab software is driving experiment duplication, workflow bottlenecks, and risky shadow AI use

The Medicine Maker

February 09, 2026

How Language Shapes Care 

ACP examines ethical implications of calling all physicians “providers”

Conexiant